Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1911739rdf:typepubmed:Citationlld:pubmed
pubmed-article:1911739lifeskim:mentionsumls-concept:C1708335lld:lifeskim
pubmed-article:1911739lifeskim:mentionsumls-concept:C0008328lld:lifeskim
pubmed-article:1911739lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:1911739lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1911739lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1911739pubmed:issue2lld:pubmed
pubmed-article:1911739pubmed:dateCreated1991-11-18lld:pubmed
pubmed-article:1911739pubmed:abstractTextThe authors determined whether response to cholecystokinin-tetrapeptide (CCK-4) was dose-dependent. Healthy volunteers (n = 36) received double-blind injections of either 9 micrograms, 25 micrograms, or 50 micrograms of CCK-4 and placebo in a randomized sequence of injection. Significant dose-related differences were found for the number of symptoms, sum intensity of symptoms and the time until onset of symptoms, but not for the duration of symptoms. The incidence of panic attacks with CCK-4 was 11%, 17% and 47% for the 9 micrograms, 25 micrograms and 50 micrograms dose, respectively. None of the controls panicked with placebo injections. These results support the notion of a dose-dependent effect of CCK-4-induced panic symptoms. Implications of these findings in the neurobiology of panic attacks are discussed.lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:languageenglld:pubmed
pubmed-article:1911739pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:citationSubsetIMlld:pubmed
pubmed-article:1911739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1911739pubmed:statusMEDLINElld:pubmed
pubmed-article:1911739pubmed:monthJullld:pubmed
pubmed-article:1911739pubmed:issn1180-4882lld:pubmed
pubmed-article:1911739pubmed:authorpubmed-author:BourinMMlld:pubmed
pubmed-article:1911739pubmed:authorpubmed-author:BradwejnJJlld:pubmed
pubmed-article:1911739pubmed:authorpubmed-author:KoszyckiDDlld:pubmed
pubmed-article:1911739pubmed:issnTypePrintlld:pubmed
pubmed-article:1911739pubmed:volume16lld:pubmed
pubmed-article:1911739pubmed:ownerNLMlld:pubmed
pubmed-article:1911739pubmed:authorsCompleteYlld:pubmed
pubmed-article:1911739pubmed:pagination91-5lld:pubmed
pubmed-article:1911739pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:meshHeadingpubmed-meshheading:1911739-...lld:pubmed
pubmed-article:1911739pubmed:year1991lld:pubmed
pubmed-article:1911739pubmed:articleTitleDose ranging study of the effects of cholecystokinin in healthy volunteers.lld:pubmed
pubmed-article:1911739pubmed:affiliationDepartment of Psychiatry, McGill University, St. Mary's Hospital, Montreal, Quebec, Canada.lld:pubmed
pubmed-article:1911739pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1911739pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1911739pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:1911739pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1911739lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1911739lld:pubmed